Zepbound Patients’ Class Action Over CVS Caremark Formulary Decision
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
CVS Caremark · Zepbound and pharmacy-benefit formulary coverage
Last updated
About this case
Zepbound patients brought a class-action lawsuit challenging CVS Caremark’s prior decision to remove Zepbound from its preferred formulary and give Wegovy exclusive preferred status, disputing the assertion that the drugs were interchangeable. The current procedural stage is not specified.
Case overview
- Defendant company
- CVS Caremark
- Product or service
- Zepbound and pharmacy-benefit formulary coverage
- Lawsuit type
- Consumer
- Reported harm
- Competition Pricing
Participation information
Availability is based on each listed participation option and its deadline.
No active participation options are currently listed.
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.